From the Washington Drug Letter Online
Nov. 27, 2006
Biotechnology Development Costs Top $1.2 Billion Per Product
The average cost of developing a new therapeutic biotechnology product is more than $1.2 billion, including the costs of drugs that fail in testing and the time associated with bringing these products to market, according to a new study by the Tufts Center for the Study of Drug Development.
1 comment:
Zonkers Cargo Cult Scientist, that's insane!!! You'd think they would work better for that kind of money.
Post a Comment